ATE206927T1 - Aufnehmbare zubereitungen enthaltend wasserlösliche, hochviskose cellulosether - Google Patents

Aufnehmbare zubereitungen enthaltend wasserlösliche, hochviskose cellulosether

Info

Publication number
ATE206927T1
ATE206927T1 AT92301720T AT92301720T ATE206927T1 AT E206927 T1 ATE206927 T1 AT E206927T1 AT 92301720 T AT92301720 T AT 92301720T AT 92301720 T AT92301720 T AT 92301720T AT E206927 T1 ATE206927 T1 AT E206927T1
Authority
AT
Austria
Prior art keywords
soluble
levels
compositions
containing water
highly viscous
Prior art date
Application number
AT92301720T
Other languages
English (en)
Inventor
Jennifer B Dressman
Christos Reppas
Stephen W Tobey
Cynthia W Sowle
Original Assignee
Univ Michigan
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27098725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE206927(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Michigan, Dow Chemical Co filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE206927T1 publication Critical patent/ATE206927T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/18—Carbohydrates
    • A21D2/188—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT92301720T 1991-03-01 1992-02-28 Aufnehmbare zubereitungen enthaltend wasserlösliche, hochviskose cellulosether ATE206927T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66338191A 1991-03-01 1991-03-01
US87060192A 1992-02-21 1992-02-21

Publications (1)

Publication Number Publication Date
ATE206927T1 true ATE206927T1 (de) 2001-11-15

Family

ID=27098725

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92301720T ATE206927T1 (de) 1991-03-01 1992-02-28 Aufnehmbare zubereitungen enthaltend wasserlösliche, hochviskose cellulosether

Country Status (16)

Country Link
EP (1) EP0502666B2 (de)
JP (1) JP3436537B2 (de)
KR (1) KR100227002B1 (de)
AT (1) ATE206927T1 (de)
AU (2) AU669654B2 (de)
CA (1) CA2062091C (de)
DE (1) DE69232126T3 (de)
ES (1) ES2168256T3 (de)
FI (1) FI933809L (de)
HU (1) HU222487B1 (de)
IE (1) IE920660A1 (de)
IL (1) IL101113A (de)
MX (1) MX9200888A (de)
NO (1) NO304968B1 (de)
NZ (1) NZ241778A (de)
WO (1) WO1992015312A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions
US6432442B1 (en) * 1998-02-23 2002-08-13 Mcneil-Ppc, Inc. Chewable product
US6899892B2 (en) 2001-12-19 2005-05-31 Regents Of The University Of Minnesota Methods to reduce body fat
EP2079476B1 (de) * 2006-10-20 2014-05-21 Dow Global Technologies LLC Verwendung hydroxypropylmethylcellulose zur vorbeugung oder behandlung des stoffwechselsyndroms
ITFI20120268A1 (it) 2012-12-03 2014-06-04 Diopeite Consulting Ltd Composizioni farmaceutiche per il trattamento dell'obesita'
WO2015066035A1 (en) * 2013-10-28 2015-05-07 The Forsyth Institute Compositions and methods for evaluating metabolic syndrome and related diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802741A (en) * 1953-09-21 1957-08-13 Dow Chemical Co Cake mixes containing water-soluble cellulose ethers
US3709876A (en) * 1972-04-10 1973-01-09 Dow Chemical Co Water soluble hydroxyethyl methyl cellulose ether thickener for latex paint
US4284649A (en) 1977-11-22 1981-08-18 Wiczer Sol B Thickened gelatinous edible alcoholic medicated carrier
US4451490A (en) * 1982-03-08 1984-05-29 General Foods Corporation High quality, reduced-calorie cake containing cellulose and process thereof
NZ207125A (en) * 1983-02-17 1986-07-11 Merrell Pharma Inc Bulk laxative composition containing water-soluble cellulose ether
FI895708A7 (fi) * 1989-02-10 1990-08-11 Alko Ab Oy Vesiliukoinen hajoamistuote

Also Published As

Publication number Publication date
AU669654B2 (en) 1996-06-20
AU1127492A (en) 1992-08-27
DE69232126T3 (de) 2008-07-17
MX9200888A (es) 1994-07-29
FI933809A0 (fi) 1993-08-31
IL101113A0 (en) 1992-11-15
JP3436537B2 (ja) 2003-08-11
KR100227002B1 (ko) 1999-10-15
IL101113A (en) 1999-11-30
EP0502666B1 (de) 2001-10-17
CA2062091C (en) 2002-12-17
IE920660A1 (en) 1992-09-09
WO1992015312A1 (en) 1992-09-17
NO304968B1 (no) 1999-03-15
JPH06507393A (ja) 1994-08-25
ES2168256T3 (es) 2002-06-16
NO933101L (no) 1993-10-19
FI933809A7 (fi) 1993-10-01
CA2062091A1 (en) 1992-09-02
NO933101D0 (no) 1993-08-31
NZ241778A (en) 1995-04-27
AU689035B2 (en) 1998-03-19
EP0502666A1 (de) 1992-09-09
EP0502666B2 (de) 2007-11-21
DE69232126T2 (de) 2002-06-27
HU222487B1 (hu) 2003-07-28
HUT67327A (en) 1995-03-28
DE69232126D1 (de) 2001-11-22
FI933809L (fi) 1993-10-01
AU5200096A (en) 1996-07-18

Similar Documents

Publication Publication Date Title
Proesmans et al. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes
Fu et al. Bioavailability of tocotrienols: evidence in human studies
Mitra et al. Cholesterol solubilization in aqueous micellar solutions of quillaja saponin, bile salts, or nonionic surfactants
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
IL87149A (en) 6-Piperazinyl derivatives of purine and its 3- and 9-deaza isosteres, their preparation and pharmaceutical compositions containing them
BR9612693A (pt) Composição de estanol e uso da mesma.
BR9814672A (pt) Preparação farmacêutica sob a forma de comprimidos de esferóides e processo de fabricação da mesma
BRPI0412241A (pt) formulação para medicamentos de proteìna sem adição de albumina de soro humano (hsa)
DE69114498D1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
BR9507846A (pt) Composição farmacéutica estável e fortemente concentrada de principio ativo da classe dos taxóides escolhido entre o docetaxol ou os derivados do docetaxol processo de preparação desta composição e utilização de uma solução congelada ou liofilizada
FR2651678B1 (fr) Composition pharmaceutique a base de salmeterol et de dipropionate de beclometasone.
ATE206927T1 (de) Aufnehmbare zubereitungen enthaltend wasserlösliche, hochviskose cellulosether
CA2171675A1 (fr) Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
Montagud-Marrahi et al. Liposomal iron in moderate chronic kidney disease
KR930001903A (ko) 유비데카레논 경구용 수용액 제제
TR200100897T2 (tr) Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri.
JP2671353B2 (ja) 点眼剤
UY25510A1 (es) Procedimiento para la producción de preparados efervescentes
KR880003628A (ko) 처리된 리피드 조절제
KR940013503A (ko) 동맥경화증의 예방 또는 치료용 약제학적 조성물
Awazu et al. The herbal medicine Sairei-to inhibits proliferation of rat mesangial cells
KR910005886A (ko) 안정화 백혈구 인터페론
Brunner et al. Effect of simulated weightlessness on phase II drug metabolism in the rat
BR0115506A (pt) Composições farmacêuticas tendo uma ação antidiabética, e processo para sua preparação

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties